Allan D. Spigelman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Allan D. Spigelman has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- David Williams
Head of Department of Gastroenterology and Hepatology, St Vincent’s Hospital, Sydney, Australia
29 shared publications - Alex Boussioutas
Peter MacCallum Cancer Centre
28 shared publications - Arun Gupta
12Honorary Research Fellow, Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Melbourne, Australia
28 shared publications - Aysha Al-Ani
Department of Gastroenterology The Royal Melbourne Hospital Melbourne Victoria Australia
28 shared publications - Brooke E. Flanders
National Study Co-ordinator, Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Victoria, Australia
28 shared publications - Digsu Negesse Koye
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), Melbourne Medical School, The University of Melbourne, Melbourne, Australia
28 shared publications
Latest Publications
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Descriptive statistics for polyp counts of each size in the large bowel intention to treat population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Descriptive statistics for polyp counts of each size in the large bowel intention to treat population
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on global polyp burden in the large bowel PP population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 8 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on global polyp burden in the large bowel PP population
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 18 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Severity of adverse events by system organ class and treatment sequence
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 18 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Severity of adverse events by system organ class and treatment sequence
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 11 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on tattoo 1 polyp burden in the large bowel ITT population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 11 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on tattoo 1 polyp burden in the large bowel ITT population
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 21 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Summary of protocol deviations
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 21 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Summary of protocol deviations
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Descriptive statistics for polyp counts of each size in tattoo 1 and 2 in the intention to treat population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Descriptive statistics for polyp counts of each size in tattoo 1 and 2 in the intention to treat population
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 13 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on tattoo 2 polyp burden in the large bowel PP population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 13 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on tattoo 2 polyp burden in the large bowel PP population
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 14 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Mean difference for effects of treatment and time point on modified gastrointestinal quality of life index
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 14 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Mean difference for effects of treatment and time point on modified gastrointestinal quality of life index
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on global polyp burden in the large bowel excluding participants with video issues ITT population
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from The Effect of Butyrylated Starch on Bowel Polyps in Familial Adenomatous Polyposis: Results of a Randomized, Double-blind, Placebo-Controlled Crossover Trial
Ratio of mean counts for effect of treatment, week and carry-over on global polyp burden in the large bowel excluding participants with video issues ITT population